Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1vajY0eV9EMklxRFRVVDhMNkRaYXdxU0dfbmlhbkJmdVZ3eWFub2lwM01nTFJMdjJfMXNvMGF4SE9ndzkyeXprYTlQdm5heGpxelhlZnBSNVI3UzBi?oc=5" target="_blank">Researchers uncover dual role of B7-H3 in tumor immune suppression</a>&nbsp;&nbsp;<font color="#6f6f6f">EurekAlert!</font>
Champions League Matchday 2: Key stats and what to look out for in every game
Victims of Pennsylvania mass shooting included pregnant daughter of gunman
Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday
Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQT3A1RHdJS0Nyc3FPVjFlN2kxN3gzdGVwOFR2YmIyRENqTWJVb0tlNHpqSk5vT0JKdUE3QjU5dTktR2UwdTI1Y1h5T3A1QmhaYW5zRllWdDhKUHBfV19KTTlXMTJ6QjNxeFphMVhTVFdVdVdrbTA0WFpGT2xTb3ZLSjdYYw?oc=5" target="_blank">What Is Combination Therapy for Lung Cancer?</a>&nbsp;&nbsp;<font color="#6f6f6f">Yale Medicine</font>
<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxPS3B2MjA5b0VaR1ItelEtQTJBd3ljTmVkQnVWY1N6bGxGTHc3VnFxMnVWSDZOYzVaazVGdzh2Wk5WMWhyMnRFamVsc2V1cUJBNjVRTTQ1SDBQZFZ3RFpYUEJPbk9tMDZNTmZrZmt6c2RUZDVVWTRqTjVkMm51ejFtQVZfNHlyYVp4Y2o1OEhVaUJQdzFFQXlCczhxZ0lScW5pNVRrT1lZVGgyTkFEejE2Q25qcWxacGVFd3dZSDRjbGxFeTlHX0xTUFFMN3FsZWlPNkdmWEliT0x2QllHZVdCVDhnZ0haZ0VZSHB1RTBlOU96c1I0aUtRRjRNSVY2M1VvcVVF?oc=5" target="_blank">Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas</a>&nbsp;&nbsp;<font color="#6f6f6f">Boehringer Ingelheim</font>
<a href="https://news.google.com/rss/articles/CBMixwJBVV95cUxOeW1fc1NOakN2bmpSZ3hfTWlIR1prTmxpU2JHVXVJamJod0FrNndkQzZaUExfRTJCc3lOS2p3M2ExWjlKRXRHVDZ4a3FPR25YaUhvTFNSTEhfaUlrdkNwZFY1WDBWOXRaQ3FBaDYxWXRjSUVzWkhYWEVnd2ZuQkNfZDAyVXVwMFFkN0stSllwMkpQSi1LOTY0ckEwVEJzLUJEd1lWeUdoaldsbUJWQ25RM2FHTmpNYTVETmJaS2Uwb3JLdXB5U1pOQUViNVFjYV9kWUpCWEMxUUxfb2FIek1rQVo2V3VMZXdkMjRfdDhxbkJVWW5aV1NJeEdCNVp5dlBQck9ZWmsyQkdpQlp0ejNCLTZFZnZpRE9xVHVEYlM2cVp3bXpTbDRaVWJfQ2JXbVVsVXQ4UUl0TnlVeWRrYlZoRDhUaTcwdmc?oc=5" target="_blank">Boehringer Ingelheim to evaluate innovative combination of</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQSWQwMTRPZjg4SUc3ZXVIMkFMYnJPQjZhUll3QjZWbTEyVkVCMi13QnY1Wlh5OXhHNEZQOUhLcE91R1VCVUMxMzdyQlFRemFtUkZSMmdPUG5HajBLYWt6dHp1RGtOdG9KbENfcFNFQ3k2eFBSTWQzWHJKWDVCdGdRVGZYWm5rOUYyRVdKbnVQWDQzUUtkUkRITTdXaw?oc=5" target="_blank">Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">UCLA Health</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzRWIweTBJTVdsNGwyWjZneWF5QnhlWnpDV0JfMmlCQnZTd3JBMU1hVXJkV3FKbUtXbi1OLVBacDRwNkRZaVZIT2hrY01rOFBCa19NUnlBSG0xclJHWjdF?oc=5" target="_blank">Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE05MW9nZzBxemZrVTlzQTJWTmtMdGlZSEFPYWNrelJfSXlaTXVKcmZwWERMbjBTUjNTWG96VnhjelRRSjNSVHZIN180Nmp3b2pucEhNY3Jldw?oc=5" target="_blank">PET Imaging of PD-L1 Occupancy for Preclinical Assessment of the Efficacy of Combined Anti–PD-L1 Immunotherapy and Targeted Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Journal of Nuclear Medicine</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNUHJOdkpPQXFhZWNQLTJDcnVjaEV2VzZhNmg1anp1MldfYzByMElUc0Y2TVg2cEROS2N3MnRlOVFvLWhUZE14VWpxdk12RUdSMmgwTk9OcXg0bmJwakhneTRpZVVXZjZ6Ni1iMXhsZHJlTXhYZzd5S3hxeEhiRllETXZCanRST3VjU05yQXZfbENkQQ?oc=5" target="_blank">Quantifying treatment response to a macrophage-targeted therapy in combination with immune checkpoint inhibitors after exposure to conventional chemotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE0ySkRhR1dvandqTnkwcy10YUJIN2ZtQm1fQ1doQmJyNlV0SHF4RkpWQVF5d256SFE2aUY2UDl4bkZ0SzZFUlNnTEJVUXdYNVJFdHRKNmN1alFqTThBd1JJZFhrcGhfRzduR0ZUMjdnak9pckltWGc?oc=5" target="_blank">Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next-Generation Approaches</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley & Sons</font>
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1DNXpqQzlPMUIyUmtXbFp6MndzSXB3WmlRLUdTcWhiT3UyQVVtUzdQWHhiVkpSQUNHRGZkMHpIcTNpUktpY3J1aUJnMnk0c0lJd1U1VFg4UFVmUQ?oc=5" target="_blank">Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Journal of Nuclear Medicine</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBVVHVsa2lLVVpWUUNUbVRRRFJFZFNuR0FxSFB3RmZsRTZVNW1FRVk5WTc3cklpXzRLTlpYNWJsOFJvTE96ODYyY0hoLXdmaVZCdm9QcDBveDNKZFhzZUR3?oc=5" target="_blank">Cold and hot tumors: from molecular mechanisms to targeted therapy | Signal Transduction and Targeted Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPSHk4akppVVEyNG1Vai1ib2dReXp4S2Ywdmd6VGdZVFlHTUlWNzU0M0RDZllZNGpFTXVrNDZzcHlWRlpfdnZ6WDRtVnhoZ09EZ1FNdzlHNjB1aG9ka0RRa3A3cDJWR1h4eHJxTXVvdTZpZUhJSGRzRGdYUDU2MTRLR1BGaEZoLUZ0d2hNVnBjMFhQUQ?oc=5" target="_blank">Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1kVFlHa2p1eS1qUXdfRUtZOHAzWS1jclRvaXgwanVfckZtU3EzLWc4akVqNW5vNUhYcDZBSjZ4c1BtZDFDNDR1VHVrR0xHR0M3QnJ4VF9DMU1lWEQ4cWtF?oc=5" target="_blank">Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxORkRpUHFxQWpCR0NCdlBUX0REWTk3QU10a1dBZV9HQ2lhaVBCdEt4ajJPb055LUwwRm9PTjkxWFAwclVUTGZhTVZiWHFtakFueEZTWXBLWml6Smw5ZWRmYnUyaUg4Qmwzb1B6YjZOOURvUzUzcmlGMVp3M2pBZVlFeE9UVU5FejhlNnBBbGVlTEw2Zw?oc=5" target="_blank">The tumor microenvironment as a key regulator of radiotherapy response</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1MZm9MY2ZPSG5UOVlPaTRIT0NQWHRYd3RvOTduYkJZMUFTbk0yY3QwVzkxZm1ORElDUnZ6R1VfcFFqeGhNNjNTa1ZvZXI2QVN5R0ctMnh0QTY1QWlKeDJZ?oc=5" target="_blank">Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPaUQ1bVE0SFc1bUdlRzFDV3F6V001SFpoWFh3LUw0bjFVU2pfWTlWYk1mcHlVUmdWOG0tdVVlR1lPRjRvNG5menRuT1JzRFE0RFpMSlVtUWhzTE95LWl2VXZBRkRLS3ZSbElRNFoxNFBsOXZqVlhLWjVmemhwWkRiSThwbUVJZEdwRFhoSER5bXFqdw?oc=5" target="_blank">Potential of small-molecule targeted drugs in combination with CAR-T cell therapy for hematologic lymphomas</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPMDY0TE9oUGo2LWpvckR1M2pTdGJ2UHB1dGhnNUNUNXYzYW5nWDhpTVd3bGxRLWZDY1NhaGx6TGtRUnFRWWxlMlFYeC1zTWc0c3hVZzB2RlRTc3Nzendz?oc=5" target="_blank">Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOVUtHRkJzV19EcHBJVWhHZFNJNl9IVmh5MFE2Wnl1aGR1WS1ESXY0NlZGeFZhNVNHczdNN2JTcTZZN0l3ak1ObjhIbkZqM2Q3VWZ2MGNETFVBS1Vzakt1YWVxNWQzdWlyRXVCREkwOFVKLVNqQ2l4dmh4c2VpZkY4RzhRbTRIVlhYbjMtUnJSc2lMZw?oc=5" target="_blank">Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQVmJrMjFab2dIN19obVlRLVhBeEZMUWZwcmJ4MjRDYmNERlRmY21TS1NjTVBXa2ZDZngwMU1CRWpRdTRtLWg5bnJWMmQyMDlKUnpWS2hSQ1p1aFh4ODNrcU0zaTJ3Nk1JV01OU1dpQVFyXzFFMTQ1ZTNWYnczdk1HaGVlcHlMb3B4VDRhWnJmUEZWUQ?oc=5" target="_blank">New dimensions of PD-1/PD-L1 inhibitor combination therapy in cancer treatment: current advances and future perspectives</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNeFZ2RGU2S1JMSEhKbUZMbGJseFBlRGR1N2lNOVh2LUk1VHNRaGdtaGprYWtCSUZ1QUc5NVNDTy1UbzdyVVE2WENXd2tTb0Y1TFpxbDhkNVd2R2txdXlnZkdUWDNNVHhJTl9wMUhDLWZSbXdocUdiVXJKMGZ4bjRwSUpwNnVZNnIzbGVPeGR5M3FSUQ?oc=5" target="_blank">Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5VTVhFQ2N3YUswaWtvVHdSREExbDIyLUFfWnBfTzZibkNJVmhIZHE3RVdPemlhekxpZkFKbnpFQ1kwMjQwMTlqVEstb01XeVNnazFzNWk0ZWttemMyRGww?oc=5" target="_blank">Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ReV9Hb0hydGQtY1pwN2NId1Y1bVpCMmdUUHphLVVLTHRmNHFZNWtNWDI0VFBMNUt3Vy00cVloQ3JfSEhta21rVzF4eWVtRUhTMThOUGtIQjNsZXV6Q3BJ?oc=5" target="_blank">Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TVTJkTkQ0OFc0QWtJS1FkUzZ6MTRxTExEdUdPS2tWU3FWcnA4Tl9KZkZKQjhHX19rMHVZNGZHZVVuSnBRWnJodWJ6TVdYZC1ZQUJycXdJdVZGX3FNZkRN?oc=5" target="_blank">Targeting cytokine and chemokine signaling pathways for cancer therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcVlXQkpWY1VLa0ptbWdGbHdmTEhQVnlXVG9SbFI1dmczWVVwbXFXUURnQTA1ODlPMDFoMWlfVUtYSEQ1alBlODNRN2stSW5TWEYxSkhzSGVzUzVBRDlNQ3hzZWo3VTl1c3YyNmNZLTJubUUtRWxnRWRkMHpsSFYzNkNkSXgwZ0NDQlBoYldacTJ4ZjJTLXF5bWxMVzRjUm5rcUdmbDNMRTA3QV8wZ3BXR2NGQTRPeG1DSl9ySU9maHh6U2s5YVBBWTh5VzR2QlhMMHdScA?oc=5" target="_blank">Immunotherapy Combined With Targeted Therapy in Patients With BRAF V600E–Mutated Colorectal Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9uRk9qVF9Idmxja2ltVm45eUFrV1E5bWppeUpxZVpPd3YxaUZnZnVibDhEOWtDMldKN2VUdVpONXZlQ2phblRhc3l3OXZqU0FkNzVPaXk2RWFPbzBTZGJZ?oc=5" target="_blank">Targeted immunotherapies and nanomedicines for ovarian cancer: the way forward</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQcGh5dl9QVlc5RlVpSUNVM2NnYkFKZHNEOE96Mk12WnV1UGVpaVFBYjFIX29MZzBRQzdGNmFFYnRpM2h1S1RvaURiMkRNQnl2Ri1xeFF5UmFQSWotbklOUU9ya2ZvRENZOEMxVWFYVWQxWW9MNXdhNGtzWExuaEVsTHE0bnB4V3gwQlIxTWNn?oc=5" target="_blank">Shaping viral immunotherapy towards cancer-targeted immunological cell death</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQdDZNSWZqVHBWZ1JOM1JiNXJNNjBkNG9SZ2QwLThVY0FIYnI2b19NcHZOWXp6Z3ZmU3pFMHRlV1RBS2hwc1RUQlI4VkJQaHhCd3BqR1hiX05xcFJsZ1V3MmwyeDNtYmNqaDMybUhDWGItaHRHa3ROU1F6bTRTYkw1ME1pei05OUpTRmdkZUx6ZnhMdkVmSXRaMGRRUVpEeDFwdTUxT3pycWVrY3ZLcWRMR3pLTE1oSnM4N2xvbVhXbE5jYk9Bd3BCT0pJV2wySEpXVjlXQW13TWlVdw?oc=5" target="_blank">Combining Targeted Radiotherapy with Immunotherapy May Improve Outcome</a>&nbsp;&nbsp;<font color="#6f6f6f">Moffitt</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQLVJZcFFuV0tnUnp6Sm96WjJqZHBjZEpYcUNYZmZYaklfenRITjAwVUJTcDRobjljS3VOZEpFcHZ1N2dLN3VXek1SRWJLZmhCVWIzWk5EaEFYQ1ItSzVNY1JYYlFLdXE2Y09BeU5uMEpaT0ZIc3lYV19TVkI2LS1MTXcxRnNPNlliMENNa3ZLMWllUQ?oc=5" target="_blank">A new target of radiotherapy combined with immunotherapy: regulatory T cells</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPendia0JjNmoyaUdxVnVQbmEwX0Y3Rkk1bzlmNGw2Vk50cHVlOEF6YzlkZnF1TmlZUmpIcmpzbDhMa2Y1T2UtZWxLZjc2MVg1WnJyRzdsUEpJRm9FVUJwU2d4OUZHb0VhYTg3cl9KeFJGb3Bwa0hGVzZIbGZKQTVJVlZ4aDdfcXhvbUNvVGhvWWZPZw?oc=5" target="_blank">CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOdjJRQTJBVjVXWnpVSTh4cGV6blFQcjJyRXRMZDZmVG5DZHQ1Y1BGTXh5NzF6MVd6YkNwQXdQbmUzNHVZeTdPakJzbzZnOWMtUXlFd1VpWkIwdF9sTWN3dkQxd2VCMVBkOGtsQ2FOaTlSQUZHWTFEV0N4a083bmJSNVREaEw3RXotQmFncHMyNzg0dw?oc=5" target="_blank">Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>